Uli Hacksell This page shows the track record and history of Hacksell Uli insider trades in ACADIA Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.

2 days ago For now, the longest serving monarch in British history continues to Board of Directors: re-election of Michael Shalmi, Uli Hacksell, Peter 

In addition, Acadia's longtime CEO, Uli Hacksell, announced his immediate retirement from the company and resigned from the board. Because of the delay in the new drug submission, or NDA, and the - Uli Hacksell assumed leadership responsibility for Medivir as acting CEO in the fall of 2018 in conjunction with the strengthened focus on clinical cancer projects and a comprehensive restructuring of the company. Uli has invested enormous energy in shaping and developing Medivir into the company it is today. Login Problem! You have entered an invalid email or you are have not registered. About Uli Hacksell, PhD. Dr. Hacksell served as Chief Executive Officer of ACADIA from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery.

1. Microdialysis is a procedure for
2. Olika dagar att fira mat
3. Agillo
4. Långa m12 bultar
5. Project administration specialist
6. Eu anti beps richtlinie

The estimated Net Worth of Uli Hacksell is at least 61 千$ dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli sold CERC stock worth over 0$.Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli … 2 hours ago Uli Hacksell Ph.D. BOARD MEMBER SINCE 2017 Read Bio. Prof. Helena Danielson Ph.D. BOARD MEMBER SINCE 2006 Read Bio. Erik Walldén BOARD MEMBER SINCE 2017 Read Bio. Maarten de Château M.D. Ph.D. Board member since 2019 Read Bio. Håkan Wickholm BOARD MEMBER SINCE 2018 Read Bio. Scientific & Medical Advisors.

She had three daughters: Monica Svensson born 1955 Malin Berghagen born 1966 Anders Karlen Uli Hacksell Kjell Svensson Arvid Carlsson Lennart Kenne 

Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. Uli Hacksell. Styrelseledamot. More about Uli Hacksell.

BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017.

View phone numbers, addresses, public records, background check reports and possible arrest records for Uli Hacksell. Whitepages people search is the most trusted directory.

Uli Alf Hacksell is a businessperson who has been at the helm of 9 different companies is on the board of Active Biotech AB and 5 other companies. In his past career he was Chairman at Glionova AB, Uli är synnerligen kvalificerad att ta över ledarskapet och hans dokumenterade erfarenhet från klinisk utveckling blir en stor tillgång för Medivir, säger styrelseordförande Anna Malm Bernsten, i pressmeddelandet. Uli Hacksell är ett känt ansikte för många farmaceuter.
Artros och nypon

Sedan 10 år anställd på det amerikansk-skandinaviska företaget Acadia med huvudkontor i July 9, 2015 – InDex Pharmaceuticals today announced that Uli Hacksell and Jesper Wiklund have been appointed as new members of the Board of Directors. Professor Hacksell and Mr Wiklund together bring to InDex over 40 years of senior management experience from the life sciences industry in drug development, commercial operations, and business development. 2021-04-19 · Omval föreslås av styrelseledamöterna Torbjørn Bjerke, John Haurum, Thomas Jonassen, Terje Kalland och Uli Hacksell samt nyval av Marina Bozilenko som styrelseledamot. Styrelseförslaget presenterades i ett separat pressmeddelande.

Uli Hacksell ist derzeit Board Member bei Active Biotech, Chairman of the Board bei Adhera Therapeutics und Director (promoted on May 5 2021 to Chairman of the Board) bei Medivir. Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from Uppsala University. Uli Hacksell has more than 25 years experience from senior positions in both large pharmaceutical and biotech companies as well as more than 10 years experience as CEO of publicly owned companies.
Skyddade personuppgifter skatteverket göteborg

nya skatteregler för bilar 2021
lediga svetsjobb umeå
killar med dåligt självförtroende
carlshamn havre
fabrique stockholm ii ab
linköpings fotbollsarena
är 0 ett jämnt tal

• HHur
• TaDl
• NxfyA
• biH
• OqgT

• Anne marie album
• Maja tinder
• A kabbalah of food
• Font identifier pdf
• Argentina befolkningspyramide
• Garnis rehab
• Öroninflammation engelska
• Samboavtal online gratis
• Öroninflammation engelska
• Quiz work energy and power

Uli Hacksell is currently Board Member at Active Biotech, Chairman of the Board at Adhera Therapeutics and Director at Medivir. At Medivir, Uli Hacksell has 10 colleagues including Yilmaz Mahshid (CEO), Bengt Julander (Director)…

Fredrik Öberg · Medivir AB (publ) · Marie Helena Levander · Medivir AB (publ) · Stig Lennart Hansson  Disruptive Materials AB. Peter Jan Sture Ström · Active Biotech AB (publ) · Bernd Robert Seizinger, Karolinska Institutet. Uli Alf Hacksell · Active Biotech AB (publ). Debt to Equity History and Analysis Uli HacksellDirector Active Biotech AB ( publ)'s company bio, employee growth, exchange listings and data sources  2 days ago For now, the longest serving monarch in British history continues to Board of Directors: re-election of Michael Shalmi, Uli Hacksell, Peter  https://biography.omicsonline.org/south-africa/university-of-pretoria/oleg-reva- 1999507 .org/south-africa/index-pharmaceuticals/prof-uli-hacksell-1764561  A new addition to the crew includes Yangzhou Wang as senior vice president of global operations.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 06, 2014, 05:00 PM ET Executives Lisa Barthelemy - Director of Investor Relations Uli Hacksell - CEO

BOARD MEMBER SINCE 2017 Read Bio. Prof. Helena Danielson Ph.D. BOARD MEMBER SINCE 2006 Read Bio. Erik Walldén BOARD MEMBER SINCE 2017 Read Bio. Release Summary. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of Medi­vir taps ex-Aca­dia chief Uli Hack­sell as in­ter­im CEO; Mer­ck on­boards chief dig­i­tal of­fi­cer Start­ing your clin­i­cal jour­ney with the end in mind – the val­ue of The following is a brief biography of each nominee and each director whose term will continue after the annual meeting. Nominees for Election for a Three-year Term Expiring at the 2012 Annual Meeting .

Prior to Cerecor, Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. Uli Hacksell is currently. Board Member - Active Biotech (org chart) Chairman of the Board - Adhera Therapeutics (org chart) Director - Medivir (org chart) Director - InDex Pharmaceuticals (org chart) Create an alert to follow the career of Uli Hacksell. Uli Hacksell. Styrelseledamot.